Close
Nordic 9Nordic 9

MSD Global Health Innovation Fund (investor - Corporate Investor)

United States merckghifund.com
See something wrong or missing? Let us know
Offices:New Jersey

Merck Global Health Innovation Fund (GHI) is a corporate healthcare venture capital of the American pharmaceutical company Merck & Co.

Average round investment:16.04M USD
Average number per year:1.0
Distribution: 2024 (1)2022 (1)
Portfolio companies: United Kingdom BaseimmuneHungary Turbine
Mostly invests in: United Kingdom United Kingdom (1) Health services (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to MSD Global Health Innovation Fund

Name Criteria
United States Calyx
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Learn Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Finland OP Financial Group
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Riyadh Valley Company
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing, Software Services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States rocketship.vc
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Manufacturing, Software Services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Sam Altman
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Manufacturing, Software Services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Mayo Clinic
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
New Zealand AfterWork Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States DRW Venture Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Software Services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Hong Kong Vita Spring IVD Fund
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top